Recursion Pharma director Blake Borgeson disposes of 30,000 shares valued at $100,200
RXRX•Director share sale
- Recursion Pharmaceuticals director Blake Borgeson sold 30,000 Class A common shares on Sept. 1, 2026 at $3.34.
- Direct stake fell to 6,158,287 shares following the transaction.
